SecondWave Systems Demonstrates Reduction in Disease Activity in Clinical Study Evaluating Novel Ultrasound-Based Anti-Inflammatory Therapy in Rheumatoid Arthritis

ST. PAUL, Minn.--(BUSINESS WIRE)--SecondWave Systems, Inc., a pioneer in the emerging field of bio-ultrasonic medicine, today announced completion of a pilot clinical study evaluating its novel noninvasive ultrasound stimulation technology in the treatment of patients with rheumatoid arthritis (RA). This study involved splenic ultrasound treatment of 13 participants, and showed significant improvement in disease activity, with 10 of 13 participants experiencing benefit during the treatment peri